MCQs review 13-24
Advanced Cancer Pain Management Quiz
Test your knowledge on the treatment and management of cancer pain with this comprehensive quiz designed for healthcare professionals. Dive into scenarios involving metastatic cancer and assess your understanding of effective pharmacological strategies.
- 12 multiple choice questions
- Focused on pain management in oncology
- Ideal for healthcare providers and students
A 75-year-old man diagnosed 6 months ago with stage D cancer of the prostate comes to your office. He has been asymptomatic for the past 6 months, but last week he began to develop severe pain in the lower lumbar spine. He also appears quite pale. On examination, his prostate is hard. He has tender lumbar vertebrae L2- 5. Your suspicions of metastatic bone disease are confirmed when a technetium-99 m bone scan shows increased uptake of radionuclide in L2-5 and in both femurs, both tibias, and both humeri.
1. What is the treatment of first choice at this time?
High-dose morphine sulfate
High-dose hydromorphone
Transdermal fentanyl
Palliative radiotherapy to the lumbar spine
Acetaminophen-hydrocodone
You institute appropriate therapy for this patient. He quickly becomes pain free and remains that way for 6 months. He then returns with cervical, thoracic, and lumbar back pain; bilateral thigh pain; bilateral knee and leg pain; and pain in both shoulders and both arms (diffuse). Therapeutic options at this time include which of the following?
Intravenous (IV) chlorinate
B. IV radioactive strontium
Morphine sulfate
Hydromorphone
Naproxen
All of the above
Which of the following pharmacologic agents is the drug of first choice for the treatment of mild metastatic bone pain?
Morphine sulfate
Hydromorphone
Fentanyl
D. A nonsteroidal antiinflammatory drug (NSAID)
Carbamazepine
Which of the following drugs should not be used in the management of chronic pain?
Codeine
Meperidine
Levorphanol
Methadone
A 52-Year-Old Man with Metastatic Renal Cell Carcinoma A 52-year-old man with metastatic renal cell carcinoma presents for assessment of a pain beginning in the buttocks and traveling down the left leg. It has a sharp, stabbing, burning, or “zinger-like” quality, according to the patient. The patient indicates that the baseline pain is 5 on a 10-point scale, with a range from 3 to 7. 5. What is (are) the drug(s) of first choice for the management of this patient’s cancer pain?
Carbamazepine
Hydromorphone
Morphine sulfate
Amitriptyline
Desipramine
A 66-Year-Old Woman with Metastatic Renal Cell Carcinoma A 66-year-old woman with metastatic renal cell carcinoma presents for assessment of a pain also beginning in the buttocks and traveling down the left leg. The only difference between this patient’s pain and that of the patient in Clinical Case Problem 2 is that this patient describes the pain as dull and throbbing. 6. What is (are) the drug(s) of first choice for the management of this patient’s cancer pain?
Carbamazepine
Hydromorphone
Morphine sulfate
Desipramine
Valproic acid
The location of the lesions described in the two patients presented in Clinical Case Problems 2 and 3 is best portrayed as which of the following?
Retroperitoneal
Lumbar-sacral plexopathy
Intraabdominal–visceral
A and b
E. B and c
What percentage of patients with cancer pain responds well to first-line analgesic therapy such as acetaminophen or NSAIDs?
1%
5%
10%
15%
20%
Which of the following agents would be classified as second-line analgesic therapy for the management of cancer pain?
Hydrocodone
Acetaminophen
Morphine sulfate
Levorphanol
Hydromorphone
Which of the following agents is not classified as a third-line pharmacologic agent in the management of cancer pain?
Methadone
Morphine sulfate
Hydromorphone
fentanyl
Codeine
A patient comes to your office with moderately severe cancer pain. You prescribe the third-line agent (because of the description of the pain as moderately severe). Which of the following best describes the preferred approach to management of this patient’s cancer pain?
Begin with a twice-daily oral dose of long-acting morphine
Begin with a twice-daily oral dose of long-acting morphine plus short-acting oral morphine for breakthrough pain
Begin with a dose of short-acting oral morphine every 4 hours
Begin with a transdermal fentanyl analgesic patch
Begin with a dose of 200 mg morphine/day in any form
A patient who is maintained with long-acting morphine and short-acting morphine for breakthrough pain presents with a 1-week history of an increasing need for short-acting morphine. He is now taking three times the number of short- acting tablets as previously. What should you do at this time?
Prescribe more short-acting morphine; keep the amount of long-acting morphine the same
Transfer the increased requirement into long-acting morphine and maintain a supply of short-acting morphine
C. Transfer the increased requirement into both increased amounts of long-acting morphine and increased amounts of short-acting morphine
Switch to another third-line oral agent
Switch to a transdermal delivery system
{"name":"MCQs review 13-24", "url":"https://www.quiz-maker.com/QPREVIEW","txt":"Test your knowledge on the treatment and management of cancer pain with this comprehensive quiz designed for healthcare professionals. Dive into scenarios involving metastatic cancer and assess your understanding of effective pharmacological strategies.12 multiple choice questionsFocused on pain management in oncologyIdeal for healthcare providers and students","img":"https:/images/course4.png"}
More Quizzes
MCQs review 25-36
12615
18 august ( 109 - 120 )
12618
Antineoplastic Agents
10516
22 Aug 2022 ( 157-168 )
13613
CRAU Induction Quiz
1059
Palliative quiz
12610
23 Aug 2022 ( 169-180 )
13613
Palliative quiz
12617
MCQ review
12619
Daily Weights / I&O's
5242
Quick Questions About Commonly Used Drugs in A&E
520
PAIN MANAGEMENT
10511